{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:00:56Z","timestamp":1781276456207,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":31,"publisher":"Springer New York","isbn-type":[{"value":"9781493986118","type":"print"},{"value":"9781493986125","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-8612-5_19","type":"book-chapter","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T10:55:15Z","timestamp":1532948115000},"page":"267-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["C3 Transferase Gene Therapy for Continuous RhoA Inhibition"],"prefix":"10.1007","author":[{"given":"Angel J.","family":"Santiago-Lopez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire-Anne","family":"Gutekunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0041-0101(01)00152-0","volume":"39","author":"C Wilde","year":"2001","unstructured":"Wilde C, Aktories K (2001) The Rho-ADP-ribosylating C3 exoenzyme from Clostridium botulinum and related C3-like transferases. Toxicon 39:1647\u20131660","journal-title":"Toxicon"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/oxfordjournals.jbchem.a021209","volume":"119","author":"T Miyaoka","year":"1996","unstructured":"Miyaoka T, Tsuchiya M, Hara N, Ishino H, Shimoyama M (1996) Activation of Clostridium botulinum C3 exoenzyme-catalyzed ADP-ribosylation of RhoA by K+ in a Mg2+-dependent manner. J Biochem 119:200\u2013207","journal-title":"J Biochem"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrmicro2592","volume":"9","author":"K Aktories","year":"2011","unstructured":"Aktories K (2011) Bacterial protein toxins that modify host regulatory GTPases. Nat Rev Microbiol 9:487\u2013498","journal-title":"Nat Rev Microbiol"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.aanat.2011.02.015","volume":"193","author":"M Auer","year":"2011","unstructured":"Auer M, Hausott B, Klimaschewski L (2011) Rho GTPases as regulators of morphological neuroplasticity. Ann Anat 193:259\u2013266","journal-title":"Ann Anat"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1523\/JNEUROSCI.19-17-07537.1999","volume":"19","author":"M Lehmann","year":"1999","unstructured":"Lehmann M, Fournier A, Selles-Navarro I, Dergham P, Sebok A, Leclerc N, Tigyi G, McKerracher L (1999) Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 19:7537\u20137547","journal-title":"J Neurosci"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.2174\/1381612811319240007","volume":"19","author":"L McKerracher","year":"2013","unstructured":"McKerracher L, Guertin P (2013) Rho as a target to promote repair: translation to clinical studies with cethrin. Curr Pharm Des 19:4400\u20134410","journal-title":"Curr Pharm Des"},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"E535","DOI":"10.1016\/j.wneu.2013.01.009","volume":"82","author":"N Forgione","year":"2014","unstructured":"Forgione N, Fehlings MG (2014) Rho-ROCK inhibition in the treatment of spinal cord injury. World Neurosurg 82:E535\u2013E539","journal-title":"World Neurosurg"},{"key":"19_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.191","volume":"5","author":"JC Koch","year":"2014","unstructured":"Koch JC, T\u00f6nges L, Barski E, Michel U, B\u00e4hr M, Lingor P (2014) ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS. Cell Death Dis 5:e1225","journal-title":"Cell Death Dis"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.expneurol.2005.12.002","volume":"198","author":"CI Dubreuil","year":"2006","unstructured":"Dubreuil CI, Marklund N, Deschamps K, McIntosh TK, McKerracher L (2006) Activation of Rho after traumatic brain injury and seizure in rats. Exp Neurol 198:361\u2013369","journal-title":"Exp Neurol"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-11113-3","volume":"7","author":"S Mulherkar","year":"2017","unstructured":"Mulherkar S, Firozi K, Huang W, Uddin MD, Grill RJ, Costa-Mattioli M, Robertson C, Tolias KF (2017) RhoA-ROCK inhibition reverses synaptic remodeling and motor and cognitive deficits caused by traumatic brain injury. Sci Rep 7:1\u201312","journal-title":"Sci Rep"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/ncomms3189","volume":"4","author":"AU Gurkar","year":"2013","unstructured":"Gurkar AU, Chu K, Raj L, Bouley R, Lee S-H, Kim Y-B, Dunn SE, Mandinova A, Lee SW (2013) Identification of ROCK1 kinase as a critical regulator of Beclin1-mediated autophagy during metabolic stress. Nat Commun 4:2189","journal-title":"Nat Commun"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2012.09.010","volume":"25","author":"A Mleczak","year":"2013","unstructured":"Mleczak A, Millar S, Tooze SA, Olson MF, Chan EYW (2013) Regulation of autophagosome formation by Rho kinase. Cell Signal 25:1\u201311","journal-title":"Cell Signal"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"13153","DOI":"10.1074\/jbc.M809229200","volume":"284","author":"PO Bauer","year":"2009","unstructured":"Bauer PO, Wong HK, Oyama F, Goswami A, Okuno M, Kino Y, Miyazaki H, Nukina N (2009) Inhibition of Rho kinases enhances the degradation of mutant huntingtin. J Biol Chem 284:13153\u201313164","journal-title":"J Biol Chem"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1523\/JNEUROSCI.2336-15.2016","volume":"36","author":"EG Gentry","year":"2016","unstructured":"Gentry EG, Henderson BW, Arrant AE, Gearing M, Feng Y, Riddle NC, Herskowitz JH (2016) Rho kinase inhibition as a therapeutic for progressive supranuclear palsy and corticobasal degeneration. J Neurosci 36:1316\u20131323","journal-title":"J Neurosci"},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/jnc.13688","volume":"138","author":"BW Henderson","year":"2016","unstructured":"Henderson BW, Gentry EG, Rush T, Troncoso JC, Thambisetty M, Montine TJ, Herskowitz JH (2016) Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer\u2019s disease and ROCK1 depletion reduces amyloid-\u03b2 levels in brain. J Neurochem 138:525\u2013531","journal-title":"J Neurochem"},{"key":"19_CR16","doi-asserted-by":"publisher","first-page":"19086","DOI":"10.1523\/JNEUROSCI.2508-13.2013","volume":"33","author":"JH Herskowitz","year":"2013","unstructured":"Herskowitz JH, Feng Y, Mattheyses AL, Hales CM, Higginbotham LA, Duong DM, Montine TJ, Troncoso JC, Thambisetty M, Seyfried NT, Levey AI, Lah JJ (2013) Pharmacologic inhibition of ROCK2 suppresses amyloid-\u03b2 production in an Alzheimer\u2019s disease mouse model. J Neurosci 33:19086\u201319098","journal-title":"J Neurosci"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.mcn.2011.06.002","volume":"48","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Kim J, Insolera R, Peng X, Fink DJ, Mata M (2011) Rho GTPase regulation of \u03b1-synuclein and VMAT2: Implications for pathogenesis of Parkinson\u2019s disease. Mol Cell Neurosci 48:29\u201337","journal-title":"Mol Cell Neurosci"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuroscience.2016.10.022","volume":"339","author":"C-A Gutekunst","year":"2016","unstructured":"Gutekunst C-A, Tung JK, McDougal ME, Gross RE (2016) C3 transferase gene therapy for continuous conditional RhoA inhibition. Neuroscience 339:308\u2013318","journal-title":"Neuroscience"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1083\/jcb.200301080","volume":"162","author":"CI Dubreuil","year":"2003","unstructured":"Dubreuil CI, Winton MJ, McKerracher L (2003) Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol 162:233\u2013243","journal-title":"J Cell Biol"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.molmed.2007.08.002","volume":"13","author":"JM Gump","year":"2007","unstructured":"Gump JM, Dowdy SF (2007) TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med 13:443\u2013448","journal-title":"Trends Mol Med"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/s11095-007-9454-6","volume":"24","author":"EYM Tan","year":"2007","unstructured":"Tan EYM, Law JWS, Wang CH, Lee AYW (2007) Development of a cell transducible RhoA inhibitor TAT-C3 transferase and its encapsulation in biocompatible microspheres to promote survival and enhance regeneration of severed neurons. Pharm Res 24:2297\u20132308","journal-title":"Pharm Res"},{"key":"19_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101071","volume":"9","author":"A Rohrbeck","year":"2014","unstructured":"Rohrbeck A, Schr\u00f6der A, Hagemann S, Pich A, H\u00f6ltje M, Ahnert-Hilger G, Just I (2014) Vimentin mediates uptake of C3 exoenzyme. PLoS One 9:e101071","journal-title":"PLoS One"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"17668","DOI":"10.1074\/jbc.M117.798231","volume":"292","author":"A Rohrbeck","year":"2017","unstructured":"Rohrbeck A, H\u00f6ltje M, Adolf A, Oms E, Hagemann S, Ahnert-Hilger G, Just I (2017) The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif. J Biol Chem 292:17668\u201317680","journal-title":"J Biol Chem"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/JCI9639","volume":"106","author":"U Laufs","year":"2000","unstructured":"Laufs U, Endres M, Stagliano N, Amin-Hanjani S, Chui DS, Yang SX, Simoncini T, Yamada M, Rabkin E, Allen PG, Huang PL, B\u00f6hm M, Schoen FJ, Moskowitz MA, Liao JK (2000) Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 106:15\u201324","journal-title":"J Clin Invest"},{"key":"19_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00234-011-0856-0","volume":"54","author":"M Ishihara","year":"2012","unstructured":"Ishihara M, Yamanaka K, Nakajima S, Yamasaki M (2012) Intracranial hemorrhage after intra-arterial administration of fasudil for treatment of cerebral vasospasm following subarachnoid hemorrhage: A serious adverse event. Neuroradiology 54:73\u201375","journal-title":"Neuroradiology"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2176\/nmc.50.7","volume":"50","author":"Y Enomoto","year":"2010","unstructured":"Enomoto Y, Yoshimura S, Yamada K, Iwama T (2010) Convulsion during intra-arterial infusion of fasudil hydrochloride for the treatment of cerebral vasospasm following subarachnoid hemorrhage. Neurol Med Chir 50:7\u201311","journal-title":"Neurol Med Chir"},{"key":"19_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95\u2013105","journal-title":"Biochem J"},{"key":"19_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.nbd.2011.09.014","volume":"48","author":"TB Lentz","year":"2012","unstructured":"Lentz TB, Gray SJ, Samulski RJ (2012) Viral vectors for gene delivery to the central nervous system. Neurobiol Dis 48:179\u2013188","journal-title":"Neurobiol Dis"},{"key":"19_CR29","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/gt.2008.65","volume":"15","author":"JF Wright","year":"2008","unstructured":"Wright JF (2008) Manufacturing and characterizing AAV-based vectors for use in clinical studies. Gene Ther 15:840\u2013848","journal-title":"Gene Ther"},{"key":"19_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneumeth.2010.12.011","volume":"195","author":"SK Schmitz","year":"2011","unstructured":"Schmitz SK, Hjorth JJJ, Joemai RMS, Wijntjes R, Eijgenraam S, de Bruijn P, Georgiou C, de Jong APH, van Ooyen A, Verhage M, Cornelisse LN, Toonen RF, Veldkamp W (2011) Automated analysis of neuronal morphology, synapse number and synaptic recruitment. J Neurosci Methods 195:185\u2013193","journal-title":"J Neurosci Methods"},{"key":"19_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/mt.2008.256","volume":"17","author":"M Flinterman","year":"2009","unstructured":"Flinterman M, Farzaneh F, Habib N, Malik F, G\u00e4ken J, Tavassoli M (2009) Delivery of therapeutic proteins as secretable TAT fusion products. Mol Ther 17:334\u2013342","journal-title":"Mol Ther"}],"container-title":["Methods in Molecular Biology","Rho GTPases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8612-5_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T10:58:43Z","timestamp":1532948323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8612-5_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493986118","9781493986125"],"references-count":31,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8612-5_19","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}